FDA Approves First Targeted Therapeutic Based on Tumor Biomarker, Not Tumor Origin
On Monday, the U.S. Food and Drug Administration (FDA) announced the highly anticipated approval of the molecularly targeted therapeutic...
Year: 2018: 2018
On Monday, the U.S. Food and Drug Administration (FDA) announced the highly anticipated approval of the molecularly targeted therapeutic...
During the early part of November, we saw the U.S. Food and Drug Administration (FDA) approve a new molecularly...
Much of the excitement revolving around cancer immunotherapy is focused on checkpoint inhibitors – drugs that “release the brakes”...
Cancer patient advocates take on many roles in their communities. They may go out to churches to promote the...
Dong-Joo (Ellen) Cheon, PhD, Assistant Professor of Regenerative and Cancer Cell Biology at Albany Medical College and the 2017...
Thanks to decades of cancer research that have brought us groundbreaking discoveries and treatments, 15.5 million U.S. cancer survivors...
When Michael Lawing was diagnosed with stage 3 renal cell carcinoma in 1997, he knew almost nothing about the...
The lung cancer death rate—the number of lung cancer deaths per 100,000 U.S. men and women—has been decreasing slowly...
In the 1970s television series The Six Million Dollar Man, the narrator says of severely injured astronaut Steve Austin:...
Back for the month of October are the editors’ picks from the eight esteemed scientific journals published by the...